This Hispanic Heritage Month, we are showcasing the story of Alicia Clark, District Sales Lead, Rheumatology, as it is an inspiration to those around her both inside and outside UCB.

Kim Moran, UCB’s U.S. Head of Insights to Impact, is dedicated to UCB’s overall mission of creating value for people living with severe diseases. With an extensive knowledge of data and science, gained during her 14 years at UCB, Kim has put her ability to glean insights from available data to develop solutions that seek to improve the lives of people living with severe diseases.

UCB’s robust global R&D response during COVID-19 focused on our patients, employees, and our communities. Read more on our overall approach from UCB's Chief Medical Officer, Iris Loew-Friedrich.  

Each year, UCB has the honor of awarding our UCB Family Epilepsy Scholarship to deserving individuals living with epilepsy, their family members, and caregivers to help them fulfill their dreams. We realize that to truly make an impact on patients’ lives, we must go beyond developing and delivering medicines, and we are committed to helping patients and their families receive the financial support they need to live their best lives possible.

This August, the theme for Psoriasis Action Month is ‘All of Us.’ UCB is joining the National Psoriasis Foundation to shine light on the condition’s impact on diverse populations, and celebrate the diversity and inclusivity of the psoriasis community. Read more from Rhonda Peebles, Head of U.S. Dermatology, as she shares her thoughts on racial inequities in dermatology and the steps UCB is taking to move the equity needle forward. 

As part of Psoriasis Action Month, Camille Lee, Head of U.S. Immunology at UCB, shares how UCB is helping find and bridge gaps in psoriatic disease care.